Ex-FDA Executive Warns Big Pharma is Banning Health Supplements | Daniel Fabricant

Danny Jones
01:57:11 Report Issue
Loading transcript... Click for full transcript

Chapters & Sections (55)

2:33 US Healthcare System and Outcomes chapter 3
2:33 Healthcare Outcomes and Spending in the US
6:12 Comparing Healthcare Systems and Outcomes in the US and China
8:45 Regulation of Dietary Supplements and Adulteration
11:18 Regulation and Accountability in Food Safety chapter 3
11:18 FDA's Role and Accountability in Food Safety
13:56 Patent Protection and Pharmaceutical Drugs
16:29 Patent Life Extension and Industry Challenges
19:01 Patent Protection and Pharmaceutical Drugs chapter 3
19:01 Industry Challenges and the Need for Specificity in IP Protection
21:28 Regulatory Challenges and Misinformation in the CBD Market
23:56 Enforcement of GMPs and Dietary Supplement Regulation
26:32 Regulatory Challenges and Dietary Supplements chapter 3
26:32 USP Labs and Enforcement of GMPs
29:02 NAC Regulation and FDA's Line in the Sand
31:31 Amazon's Influence on the Dietary Supplement Market
34:00 NAC Regulation and FDA's Actions chapter 3
34:00 Introduction to Verso and Autophagy
36:39 Introduction to Verso and Nmn
39:14 FDA's New Dietary Ingredient Notification Provision and its Impact on Supplements
41:52 Verso and Autophagy chapter 3
41:52 FDA's Attempt to Regulate Fish Oil Supplements
44:22 FDA's Regulatory Actions on Nmn Supplements
47:05 FDA's Intent Behind Regulating Nmn Supplements as Food
49:39 FDA's Regulatory Actions on Supplements chapter 3
49:39 Understanding Nmn and its Potential as a Dietary Supplement
52:09 Peptides and Their Potential as Therapeutic Agents
54:44 Status of Nmn and the FDA's Regulatory Actions
57:15 Regulatory Challenges and CBD Market chapter 4
57:15 Impact of FDA Actions on Small Companies and Online Platforms
59:50 Challenges and Successes in the Fight Against FDA Actions
1:02:22 FDA's Regulatory Actions on CBD and Cannabis
1:04:55 Regulatory Challenges and the Role of Congress or the Courts
1:07:32 Impact of FDA Actions on Small Companies chapter 4
1:07:32 Comparing FDA's Regulatory Approach to Tobacco and Cannabis
1:10:05 The Impact of Banking Restrictions on the CBD Industry
1:12:35 Alternative Banking Solutions for the CBD Industry
1:15:03 Regulatory Challenges and Telemedicine for Hormone Replacement Therapy
1:17:37 Government Overreach and Restrictions chapter 4
1:17:37 FDA's Response to the Pandemic and Dietary Supplements
1:20:11 Government Overreach and Restrictions on Dietary Supplements
1:22:40 Government Overreach and Restrictions on Dietary Supplements: The Role of Big Agencies and Pharmaceutical Companies
1:25:17 The History and Influence of the Food Pyramid
1:27:52 History and Influence of the Food Pyramid chapter 3
1:27:52 The Impact of Pharmaceutical Companies on Dietary Supplements
1:30:28 Challenges to Dietary Supplements and the Role of State Governments
1:33:00 Cancer Vaccines and Cell Therapy
1:35:36 Challenges to Dietary Supplements and State Governments chapter 3
1:35:36 The Importance of Consumer Involvement in Health Policy
1:38:08 The Importance of Consumer Involvement in Shaping Health Policies and Regulations
1:40:49 Challenges in the Current Healthcare System and Institutionalized Approach
1:43:23 Cancer Vaccines and Cell Therapy chapter 3
1:43:23 Institutionalized Approach and Regulatory Challenges in Healthcare
1:45:49 Engagement with Regulatory Agencies and Advocacy Efforts
1:50:54 Grassroots Advocacy and Lobbying Efforts

Transcript

Loading transcript...